Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 16663
Country/Region: Burundi
Year: 2017
Main Partner: FHI 360
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $2,022,138 Additional Pipeline Funding: $394,291

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $64,908
Care: Pediatric Care and Support (PDCS) $72,714
Testing: HIV Testing and Counseling (HVCT) $395,062
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $356,606
Treatment: Adult Treatment (HTXS) $1,132,848
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 91
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 76
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 91
GEND_GBV Number of people receiving post-GBV care 2018 167
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 112,329
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 3,698
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 2,525
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 1,865
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 733
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 508
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 67,266
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 1,529
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 1,056
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 732
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 578
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 14
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 15
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 606
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 472
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 667
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 528
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 4,901
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 4,105
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 9,469
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 8,946
HTS_TST Sum of Test Result disaggregates 2018 2,116
HTS_TST_POS By Test Result: Positive 2018 2,116
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 81
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 63
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 39
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 173
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 137
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 736
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 27
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 20
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 49
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 38
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 21
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 21
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 21
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 12
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Positive 2018 140
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Positive 2018 102
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 222
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 214
PMTCT_ART Already on ART at beginning of current pregnancy 2018 328
PMTCT_ART New on ART 2018 686
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 1,014
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 68,334
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 1,015
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 904
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 106
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 5
PMTCT_STAT By Age (Numerator): 15-19 2018 9,502
PMTCT_STAT By Age (Numerator): 20-24 2018 20,374
PMTCT_STAT By Age (Numerator): 25-49 2018 38,458
PMTCT_STAT By Number of known positives: 20-24 2018 19
PMTCT_STAT By Number of known positives: 25-49 2018 304
PMTCT_STAT By Number of new negative: 15-19 2018 9,498
PMTCT_STAT By Number of new negative: 20-24 2018 20,232
PMTCT_STAT By Number of new negative: 25-49 2018 37,545
PMTCT_STAT By Number of new positives: 15-19 2018 4
PMTCT_STAT By Number of new positives: 20-24 2018 123
PMTCT_STAT By Number of new positives: 25-49 2018 609
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 68,334
PMTCT_STAT_den By Age (Denominator): <15-19 2018 10,166
PMTCT_STAT_den By Age (Denominator): 10-14 2018 4
PMTCT_STAT_den By Age (Denominator): 20-24 2018 21,487
PMTCT_STAT_den By Age (Denominator): 25-49 2018 40,273
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 19
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 18
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 37
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 37
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 19
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 18
TB_PREV By Age/Sex (Numerator): <15, Female 2018 181
TB_PREV By Age/Sex (Numerator): <15, Male 2018 198
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 3,561
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 1,919
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 5,859
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 5,886
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 5,859
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 181
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 188
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 3,578
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 1,939
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 5,859
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 438
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 442
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 882
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 902
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 450
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 452
TX_CURR Aggregated Age/Sex: <15 Female 2018 455
TX_CURR Aggregated Age/Sex: <15 Female 2018 2
TX_CURR Aggregated Age/Sex: <15 Male 2018 491
TX_CURR Aggregated Age/Sex: <15 Male 2018 2
TX_CURR Aggregated Age/Sex: 15+ Female 2018 7,291
TX_CURR Aggregated Age/Sex: 15+ Male 2018 3,984
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 12,221
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 4
TX_CURR Sum of Aggregated Age/Sex <15 2018 946
TX_CURR Sum of Aggregated Age/Sex <15 2018 4
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 11,275
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 12,221
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 4
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 251
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 166
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 974
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 942
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 2,333
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 2,333
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 157
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 8,470
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 21
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 7,662
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 222
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 235
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 12
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 4,651
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 9
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 2,553
TX_PVLS Numerator: Indication: Routine 2018 21
TX_PVLS Numerator: Indication: Routine 2018 7,662
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 6
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 247
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 257
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 75
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 5,160
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 46
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 2,846
TX_PVLS_den Denominator: Indication: Routine 2018 128
TX_PVLS_den Denominator: Indication: Routine 2018 8,510
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 89
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 192
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,046
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,292
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 3,613
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 4,148
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 102
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 194
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,348
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,504
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 4,391
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 3,632
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 110
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 139
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 112
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 161
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 2,669
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 1,500
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 2,176
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 1,110
TX_TB_den Denominator: By Screen Result: Negative 2018 4,171
TX_TB_den Denominator: By Screen Result: Negative 2018 3,454
TX_TB_den Denominator: By Screen Result: Positive 2018 221
TX_TB_den Denominator: By Screen Result: Positive 2018 178